Gero Brockhoff

10PUBLICATIONS
14CO-AUTHORS
Haematological tumoursMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 07, 2025
Detection of Human Circulating and Extracellular Vesicle-Derived miRNAs in Serum of Humanized Mice Transplanted with Human Breast Cancer (HER2+ and TNBC) Cells-A Proof of Principle Investigation.

I-Peng Chen, Stefan Henning, Marc Bender

|Jul 13, 2024
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor Mice.

Veruschka Albert, Christina Bruss, Deniz Tümen

|Nov 20, 2023
Complementary Tumor Diagnosis by Single Cell-Based Cytogenetics Using Multi-marker Fluorescence In Situ Hybridization (mFISH).

Gero Brockhoff

|May 14, 2022
Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice.

Christina Bruss, Kerstin Kellner, Olaf Ortmann

|Mar 17, 2022
Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects.

Veruschka Albert, Gerhard Piendl, Dali Yousseff

|Dec 20, 2021
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease.

Anja Kathrin Wege, Eva-Maria Rom-Jurek, Paul Jank

Pageof 2

Frequent Collaborators

4 joint publications

Anja Kathrin Wege

1 joint publications

Carina Wenzel

1 joint publications

Markus Loibl

1 joint publications

Michaela Huber